Healthleap raises $38M for its AI that flags hospital patients who may need a closer look

Healthleap, a South African-founded startup that uses AI to read electronic health records and flag hospital patients at risk of undiagnosed conditions, raised $38 million across seed and Series A rounds. The financing comprises an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures.

By AI Newsroom· Reviewed by Pranav, Founder & Editor-in-ChiefPublished 30 minutes agoUpdated 30 minutes ago0 views

Healthleap raises $38M for its AI that flags hospital patients who may need a closer look

Why It Matters

The funding supports a company already deployed in over 50 hospitals and working with major U.S. health systems; its tools aim to surface underrecognized conditions such as malnutrition and delirium by extracting information from clinicians' notes and structured EHR data. If validated at scale, the technology could affect clinical workflows and hospital financials by identifying patients who may need earlier intervention.

Key Facts

Total funding: $38 million
Seed round: $8 million (co-led by Sequoia Capital and First Round Capital)
Series A: $30 million (led by Hummingbird Ventures)
Founding year and place: 2022, South Africa
Founders: Jemima and Josiah Meyer

Healthleap develops an AI-driven platform that analyzes hospital electronic health records to identify inpatients who may have undiagnosed conditions. The system combines structured data — labs, vitals, weights and medications — with information extracted from clinicians' free-text notes using language models, then generates risk scores and a dashboard for care teams. The company emphasizes that its software highlights items for review rather than making clinical diagnoses.

The startup launched in 2022 out of South Africa and initially focused on a clinical nutrition tool created by co-founder Jemima Meyer. It later broadened into a general-purpose screening platform targeting conditions that are frequently missed or detected late in hospitals, such as malnutrition and delirium. Healthleap says it has also developed programs for aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk, which are undergoing further clinical validation.

Healthleap reports deployment in more than 50 hospitals and lists customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. The company says revenue grew more than tenfold over the past year and that it has expanded from three hospital partners to more than 50. Contracts are sold on three-year terms priced by licensed bed count, and the firm also uses outcome-based pricing tied to hospital-validated ROI; Healthleap claims every customer has experienced at least a 5x hard ROI, with some reporting more than 20x.

At the Hospital of the University of Pennsylvania, the company cites a malnutrition program that produced $23.8 million in annualized financial impact, split into $6.3 million from additional reimbursement and $17.5 million from shorter lengths of stay. Healthleap plans to use the new funding for engineering, product, sales, and customer success as it adds support for more conditions, with an eventual goal of covering over 40 major health conditions and expanding into outpatient and home care settings.